54 participants
Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2025-11-20
- Completion:
- 2026-08-20
Conditions
- Age Related Macular Degeneration
- Exudative Age-Related Macular Degeneration
- Anti Vascular Endothelial Growth Factor
Interventions
- DRUG
No Results Yet